Clinical use of extra-large self-expanding stents

Yamume Tshomba; G. Melissano; E. Civilini; D. Mascia; L. Bertoglio; R. Chiesa

Clinical use of extra-large self-expanding stents

Yamume Tshomba, G. Melissano, E. Civilini, D. Mascia, L. Bertoglio, R. Chiesa

Risultato della ricerca: Contributo in rivista › Articolo in rivista

Abstract

The aim of this study is to describe our clinical experience with an extra-large self-expandable stent specifically designed to treat aortic lesions (E-XL, Jotec GmbH, Hechingen, Germany), now commercially available in Europe. The E-XL was used at our Institution in 14 patients (mean age, 56±12 years; 9 males) with the following indications: improve proximal fixation (4 cases), type I endoleak (2 cases), aortic dissection with static malperfusion (1 case) and dynamic malperfusion (7 cases). Early results have been shown to be safe and effective in different clinical settings, including in emergency cases. This peculiar aortic stent could be useful in the armamentarium of the endovascular surgeon.

Lingua originale	English
pagine (da-a)	81-87
Numero di pagine	7
Rivista	Journal of Cardiovascular Surgery
Volume	56
Stato di pubblicazione	Pubblicato - 2015

Keywords

Cardiology and Cardiovascular Medicine
Complications
Endoleak
Endovascular procedures
Stents
Surgery

Altri file e collegamenti

Fingerprint Entra nei temi di ricerca di 'Clinical use of extra-large self-expanding stents'. Insieme formano una fingerprint unica.

Cita questo

@article{6e8a57cb01c042a58fc76edcafe60d4f,

title = "Clinical use of extra-large self-expanding stents",

abstract = "The aim of this study is to describe our clinical experience with an extra-large self-expandable stent specifically designed to treat aortic lesions (E-XL, Jotec GmbH, Hechingen, Germany), now commercially available in Europe. The E-XL was used at our Institution in 14 patients (mean age, 56±12 years; 9 males) with the following indications: improve proximal fixation (4 cases), type I endoleak (2 cases), aortic dissection with static malperfusion (1 case) and dynamic malperfusion (7 cases). Early results have been shown to be safe and effective in different clinical settings, including in emergency cases. This peculiar aortic stent could be useful in the armamentarium of the endovascular surgeon.",

keywords = "Cardiology and Cardiovascular Medicine, Complications, Endoleak, Endovascular procedures, Stents, Surgery, Cardiology and Cardiovascular Medicine, Complications, Endoleak, Endovascular procedures, Stents, Surgery",

author = "Yamume Tshomba and G. Melissano and E. Civilini and D. Mascia and L. Bertoglio and R. Chiesa",

year = "2015",

language = "English",

volume = "56",

pages = "81--87",

journal = "Journal of Cardiovascular Surgery",

issn = "0021-9509",

publisher = "Edizioni Minerva Medica:Corso Bramante 83-85, 10126 Turin Italy:011 39 011 678282318, EMAIL: journals.dept@minervamedica.it, INTERNET: http://www.minervamedica.it, Fax: 011 39 011 674502",

}

TY - JOUR

T1 - Clinical use of extra-large self-expanding stents

AU - Tshomba, Yamume

AU - Melissano, G.

AU - Civilini, E.

AU - Mascia, D.

AU - Bertoglio, L.

AU - Chiesa, R.

PY - 2015

Y1 - 2015

N2 - The aim of this study is to describe our clinical experience with an extra-large self-expandable stent specifically designed to treat aortic lesions (E-XL, Jotec GmbH, Hechingen, Germany), now commercially available in Europe. The E-XL was used at our Institution in 14 patients (mean age, 56±12 years; 9 males) with the following indications: improve proximal fixation (4 cases), type I endoleak (2 cases), aortic dissection with static malperfusion (1 case) and dynamic malperfusion (7 cases). Early results have been shown to be safe and effective in different clinical settings, including in emergency cases. This peculiar aortic stent could be useful in the armamentarium of the endovascular surgeon.

AB - The aim of this study is to describe our clinical experience with an extra-large self-expandable stent specifically designed to treat aortic lesions (E-XL, Jotec GmbH, Hechingen, Germany), now commercially available in Europe. The E-XL was used at our Institution in 14 patients (mean age, 56±12 years; 9 males) with the following indications: improve proximal fixation (4 cases), type I endoleak (2 cases), aortic dissection with static malperfusion (1 case) and dynamic malperfusion (7 cases). Early results have been shown to be safe and effective in different clinical settings, including in emergency cases. This peculiar aortic stent could be useful in the armamentarium of the endovascular surgeon.

KW - Cardiology and Cardiovascular Medicine

KW - Complications

KW - Endoleak

KW - Endovascular procedures

KW - Stents

KW - Surgery

KW - Cardiology and Cardiovascular Medicine

KW - Complications

KW - Endoleak

KW - Endovascular procedures

KW - Stents

KW - Surgery

UR - http://hdl.handle.net/10807/120446

UR - http://www.minervamedica.it/en/journals/cardiovascular-surgery/archive.php

M3 - Article

VL - 56

SP - 81

EP - 87

JO - Journal of Cardiovascular Surgery

JF - Journal of Cardiovascular Surgery

SN - 0021-9509

ER -